Product Information
AMLODIPINE-ATORVAST 10-20 MG is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.9044 per EA under NDC 00378451893. Its NADAC has been published 638 times since Apr 9, 2014.
Strength
10; 20 mg/1; mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378451893
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA200465On Market Since
2/11/2014
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-ATORVAST 10-20 MG has been published 638 times since Apr 9, 2014, and over the history we have for it it has declined 86.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9044 per EA |
|---|---|
| All-time high | $6.9238 (Jul 16, 2014) |
| All-time low | $0.6922 (Jun 19, 2024) |
| 52-week high | $1.3995 |
| 52-week low | $0.9044 |
| Median price | $2.7579 |
| Average price | $3.1461 |
| Largest weekly change | +120.1% (Dec 21, 2022) |
| Weeks tracked | 638 |
| Tracking since | Apr 9, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Amlodipine and atorvastatin market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of AMLODIPINE-ATORVAST 10-20 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-ATORVAST 10-20 MG, manufactured by Mylan Pharmaceuticals Inc., is $0.9044 per EA (NDC 00378451893), effective Jun 24, 2026.
How has the price of AMLODIPINE-ATORVAST 10-20 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-ATORVAST 10-20 MG has declined 86.5%. It has been tracked across 638 weekly CMS publications since Apr 9, 2014.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-ATORVAST 10-20 MG?
Since Apr 9, 2014, the NADAC for AMLODIPINE-ATORVAST 10-20 MG has ranged from a low of $0.6922 (Jun 19, 2024) to a high of $6.9238 (Jul 16, 2014), with a median of $2.7579 per EA.
Are there cheaper alternatives to AMLODIPINE-ATORVAST 10-20 MG?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of AMLODIPINE-ATORVAST 10-20 MG, so no direct lower-cost alternative is listed.
Who manufactures AMLODIPINE-ATORVAST 10-20 MG?
AMLODIPINE-ATORVAST 10-20 MG (NDC 00378451893) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification